Pharmafile Logo

Embracing the Patient Voice Within Publications

September 5, 2023 |  

This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from internal and external stakeholders.

The biopharmaceutical sector continues to recognize the value of integrating the voice of the patient community into its activities.

Despite growing recognition of the importance of patient partnership within publications, uncertainty remains regarding how best to involve patients and where in the process this involvement should happen. Furthermore, although many of our colleagues working in Medical Affairs and publications have established the goal of engaging patients in publications, possibly as authors, their own internal guidance on publication development may create roadblocks. Compliance and regulatory concerns can limit opportunities to partner with patient communities, and the occasional reluctance of physician authors to include patients as co-authors further exacerbates the situation. Additional barriers arise from the general uncertainty in the scientific communications community as to how and when to engage patients in an appropriate manner that ensures a positive experience and recognizes the resource challenges of advocacy groups.

This paper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from internal and external stakeholders. We recognize that we are all learning together, with the shared goal of evolving our practices to fully embrace the voice of the patient while adhering to publication best practices and compliance. We welcome and encourage feedback from our industry colleagues to further refine our approaches.

This article was originally published in our latest whitepaper “Embracing the Patient Voice Within Publications”. To learn more about the multidisciplinary perspectives on how to better engage patient communities in publications, read the full whitepaper.

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

OPEN Health’s Learning & Development team have won a Bronze Award at the PM Society Digital Awards 2020

We are delighted to have won a Bronze Award at the PM Society Digital Awards 2020 for  Excellence in Innovation: Immunology Training Summit.READ MORE ABOUT OUR WINNING PROJECT WITH WITH JANSSEN BELOW:The Immunology...

OPEN VIE is awarded a Bronze Award at the PM Society Digital Awards 2020

We are delighted to have won a Bronze Award at the PM Society Digital Awards 2020 for Effectiveness: Market Access.READ MORE ABOUT OUR WINNING PROJECT “VAGUS NERVE STIMULATION - ADDRESSING INEQUALITY...

Meet OPEN Health and Pharmerit Experts at the World Pharma Pricing Market Access and Evidence Congress 2020

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Pharma Pricing Market Access and Evidence Congress from 23 – 25 September 2020, as we present:ROUNDTABLE: Wednesday, September 23,...

Reflections of a Fireside Chat from the World Orphan Drug Congress 2020

Hear from Trish Shepherd COO, Patient & Brand Communications, OPEN Health

OPEN Health has been awarded a Bronze Medal by EcoVadis

We are delighted to announce that OPEN Health has been awarded a Bronze Medal by EcoVadis for its very first Corporate Social Responsibility assessment in recognition of its commitment to Corporate Social...

Digital Therapeutics Landscape in Europe

OPEN Health introduce an overview of regulatory and HTA developments for digital therapeutics in Europe focusing on Germany and the UK

OPEN Health’s virtual reflections on the World Orphan Drug Congress US

Another congress attended in this virtual world with learnings gathered and connections made across the rare disease community. It was great to be joined by many colleagues from all our...

A day in the life of the Global Head of Publications

We asked Mina Patel to give us an insight into her role as Global Head of Publications at OPEN Health

Striving to become more patient-centric?

Explore more with OPEN Health

Meet OPEN Health and Pharmerit Experts at the World Orphan Drug Virtual USA Congress

Join OPEN Health and Pharmerit – an OPEN Health Company at the World Orphan Drug Virtual Congress from August 24-27, 2020, as we present:Advanced Therapies Commercial: Tuesday, August 25Succeeding with Star Wars...